Literature DB >> 24633705

miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.

Jun-Jie Yu1, Yin-Xia Wu, Fu-Jun Zhao, Shu-Jie Xia.   

Abstract

The present study aimed to investigate the biological functions of miR-96 in the processes of proliferation and clonogenicity in the prostate cancer cells. miR-96 was identified to be markedly up-regulated in prostate cancer cell and cancer tissues compared with normal prostate cell and normal prostate tissues by microarray method and RT-PCR analysis. Down-regulation of miR-96 expression reduced the proliferation and colony formation ability of PC3 prostate cancer cells, while over-expression of miR-96 induced proliferation and colony formation ability of LNCaP prostate cancer cells. Forkhead box protein O1 (FOXO1) is key tumor suppressors and has been shown to play key roles in the regulation of diverse cellular processes, including cell proliferation, differentiation, cell cycle progression and apoptosis. The expression level of FOXO1 was strikingly up-regulated in PC3 cells after transfected with miR-96 inhibitor, and FOXO1 expression was down-regulated in LNCaP cells after transfected with miR-96 mimics. miR-96 may play a vital role in promoting cell proliferation in human prostate cancer cells. Inhibition of miR-96 caused expression increase of tumor suppressor gene FOXO1, thus manipulating miR-96 expression may be a promising approach in treatment of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24633705     DOI: 10.1007/s12032-014-0910-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  27 in total

Review 1.  FOXO transcription factors at the interface between longevity and tumor suppression.

Authors:  Eric L Greer; Anne Brunet
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

2.  FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.

Authors:  Haijun Zhang; Yunqian Pan; Li Zheng; Chungyoul Choe; Bruce Lindgren; Eric D Jensen; Jennifer J Westendorf; Liang Cheng; Haojie Huang
Journal:  Cancer Res       Date:  2011-04-19       Impact factor: 12.701

3.  FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer.

Authors:  Xue-Yuan Dong; Ceshi Chen; Xiaodong Sun; Peng Guo; Robert L Vessella; Ruo-Xiang Wang; Leland W K Chung; Wei Zhou; Jin-Tang Dong
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

4.  Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.

Authors:  Ziqing Wu; Benfu He; Jincan He; Xiangming Mao
Journal:  Prostate       Date:  2012-10-11       Impact factor: 4.104

Review 5.  MicroRNAs in cancer: small molecules with a huge impact.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

6.  Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.

Authors:  Irene K Guttilla; Bruce A White
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

7.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

8.  Do microRNA 96, 145 and 221 expressions really aid in the prognosis of prostate carcinoma?

Authors:  Sung Gu Kang; Young Ran Ha; Seo Jin Kim; Seok Ho Kang; Hong Seok Park; Jeong Gu Lee; Jun Cheon; Chul Hwan Kim
Journal:  Asian J Androl       Date:  2012-08-06       Impact factor: 3.285

9.  miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer.

Authors:  Olivia Larne; Elena Martens-Uzunova; Zandra Hagman; Anders Edsjö; Giuseppe Lippolis; Mirella S Vredenbregt-van den Berg; Anders Bjartell; Guido Jenster; Yvonne Ceder
Journal:  Int J Cancer       Date:  2012-12-21       Impact factor: 7.396

10.  MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition.

Authors:  Yemin Wang; Jen-Wei Huang; Philamer Calses; Christopher J Kemp; Toshiyasu Taniguchi
Journal:  Cancer Res       Date:  2012-07-03       Impact factor: 12.701

View more
  24 in total

1.  MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.

Authors:  Hong-Ming Song; Yi Luo; Deng-Feng Li; Chuan-Kui Wei; Kai-Yao Hua; Jia-Lu Song; Hui Xu; Niraj Maskey; Lin Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.

Authors:  Libo Xu; Jiateng Zhong; Baofeng Guo; Qi Zhu; Hang Liang; Naiyan Wen; Wenjing Yun; Ling Zhang
Journal:  Tumour Biol       Date:  2016-05-11

3.  MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression.

Authors:  Wenbo He; Lin Feng; Dongliang Xia; Nuan Han
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Overexpression of microRNA-96-5p inhibits autophagy and apoptosis and enhances the proliferation, migration and invasiveness of human breast cancer cells.

Authors:  Yawei Shi; Yang Zhao; Nan Shao; Runyi Ye; Yin Lin; Ning Zhang; Wen Li; Yunjian Zhang; Shenming Wang
Journal:  Oncol Lett       Date:  2017-04-11       Impact factor: 2.967

5.  MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG.

Authors:  Miao Wang; Wei Gao; Dehong Lu; Lianghong Teng
Journal:  Pathol Oncol Res       Date:  2017-05-27       Impact factor: 3.201

Review 6.  MicroRNA-96: A therapeutic and diagnostic tumor marker.

Authors:  Hamid Reza Rahimi; Majid Mojarrad; Meysam Moghbeli
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

7.  MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells.

Authors:  Qing-Qing Ma; Jian-Ting Huang; Yun-Gang Xiong; Xiao-Yan Yang; Ran Han; Wang-Wen Zhu
Journal:  Technol Cancer Res Treat       Date:  2016-07-07

Review 8.  Gene interference strategies as a new tool for the treatment of prostate cancer.

Authors:  Mariarosaria Boccellino; Concetta Alaia; Gabriella Misso; Alessia Maria Cossu; Gaetano Facchini; Raffaele Piscitelli; Lucio Quagliuolo; Michele Caraglia
Journal:  Endocrine       Date:  2015-06-07       Impact factor: 3.925

Review 9.  Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis.

Authors:  Yi Ma; A-Juan Liang; Yu-Ping Fan; Yi-Ran Huang; Xiao-Ming Zhao; Yun Sun; Xiang-Feng Chen
Journal:  Oncotarget       Date:  2016-07-05

10.  Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.

Authors:  Liang Liang; Li Gao; Xiao-Ping Zou; Meng-Lan Huang; Gang Chen; Jian-Jun Li; Xiao-Yong Cai
Journal:  Mol Med Rep       Date:  2017-11-21       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.